IL6 and breast cancer: Besides, circulating inflammatory cytokines, e.g., TNF-α, IL-6, and IL-10 are discussed as potential prognostic oncomarkers in BC patients due to their contribution to cancer proliferation and invasion (Wang and Yang, 2017; Ahmad et al., 2018).